Sierra Oncology, Inc. SRRA
54.99 +54.99
Day range unavailable
52-week range unavailable
News
zacks.com GSK Receives Regulatory Nod for Consumer Healthcare Demerger GSK progresses with the separation of its Consumer Healthcare business from biopharmaceuticals into a separate public company, Haleon, as it gets regulatory approval from the FCA.
businesswire.com SIERRA ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sierra Oncology, Inc - SRRA NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Sierra…
businesswire.com SIERRA ONCOLOGY INVESTOR ALERT - Kuznicki Law PLLC Investigates Proposed Sale of Sierra Oncology, Inc - SRRA CEDARHURST, N.Y.--(BUSINESS WIRE)--Kuznicki Law PLLC is investigating the proposed sale of Sierra Oncology, Inc (NasdaqGM: SRRA) to GlaxoSmithKline plc (NYSE: GSK). Under the terms of the proposed…
stockmarket.com Best Biotech Stocks To Buy Now? 5 To Know Check out these biotech stocks with exciting developments today.
prnewswire.com SHAREHOLDER ALERT: Weiss Law Investigates Sierra Oncology, Inc. NEW YORK , April 13, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Sierra Oncology, Inc. ("Sierra" or…
invezz.com Late-Stage Biopharmaceutical Sierra Oncology announces acquisition by GSK Sierra Oncology (NASDAQ: SRRA) shares traded significantly higher after announcing the acquisition by GlaxoSmithKline PLC (LON: GSK) for $55 a share in cash. That represents a total equity value of…
investorplace.com Why Is Sierra Oncology (SRRA) Stock Up Today? Late-phase cancer treatment company Sierra Oncology is up big today after being acquired by GlaxoSmithKline. SRRA stock is soaring.
benzinga.com Sierra Oncology Stock Is Soaring: Here's Why Sierra Oncology Inc (NASDAQ: SRRA) shares are trading significantly higher Wednesday after the company announced it will be acquired by GlaxoSmithKline PLC (NYSE: GSK) for $55 per share in cash,…
schaeffersresearch.com Sierra Oncology Stock Soars After Buyout Sierra Oncology Inc (NASDAQ:SRRA) stock is soaring today, up 38% at $54.52, after news that GlaxoSmithKline (GSK) is purchasing the company for $1.9 billion.
marketwatch.com GSK to buy Sierra Oncology for $1.9 billion Shares of Sierra Oncology Inc. SRRA, +3.10% soared 37.3% in premarket trading on Wednesday after GlaxoSmithKline GSK, +0.11% GSK, +0.63% said it would buy the company for $1.9 billion. Sierra is…
barrons.com Sierra Oncology Soars After Takeover by Glaxo The deal comes ahead of GlaxoSmithKline's planned spinoff of its consumer health division in July.
fool.com Why Sierra Oncology Stock Is Soaring Today GlaxoSmithKline is adding another cancer asset to its portfolio by acquiring U.S.-based Sierra Oncology.
benzinga.com GlaxoSmithKline Scoops Up Rare Cancer-Focused Sierra Oncology In $1.9B Cash Deal GlaxoSmithKline plc (NYSE: GSK) has agreed to acquire Sierra Oncology Inc (NASDAQ: SRRA) for $55 per share in cash, representing an approximate total equity value of $1.9 billion (£1.5 billion).…
pulse2.com Why GlaxoSmithKline (GSK) Is Buying Sierra Oncology (SRRA) For $1.9 Billion GlaxoSmithKline plc (NYSE: GSK) announced it is buying Sierra Oncology, Inc (Nasdaq: SRRA) for $1.9 billion (£1.5 billion). These are the details.
marketwatch.com GlaxoSmithKline to buy Sierra Oncology for $1.9 billion Pharmaceutical giant GlaxoSmithKline PLC said Wednesday that it is buying biopharmaceutical company Sierra Oncology Inc. for $1.9 billion, and backed its guidance.- reuters.com GSK to buy Sierra Oncology for $1.9 billion Britain's GlaxoSmithKline has agreed to buy California-based biopharmaceutical company Sierra Oncology in a deal valued at $1.9 billion, the companies said on Wednesday.
businesswire.com GSK Reaches Agreement to Acquire Late-Stage Biopharmaceutical Company Sierra Oncology For $1.9bn LONDON--(BUSINESS WIRE)--GlaxoSmithKline plc (LSE/NYSE: GSK) and Sierra Oncology, Inc (Nasdaq: SRRA) today announced that the companies have entered into an agreement under which GSK will acquire…
benzinga.com Stocks That Hit 52-Week Highs On Thursday On Thursday, 75 stocks made new 52-week highs.
seekingalpha.com Sierra Oncology's Strong Data In Myelofibrosis Challenges MorphoSys And Incyte Sierra Oncology's Strong Data In Myelofibrosis Challenges MorphoSys And Incyte
businesswire.com Sierra Oncology to Present at B. Riley Securities Oncology Investor Conference SAN MATEO, Calif.--(BUSINESS WIRE)--Sierra Oncology, Inc. (NASDAQ: SRRA), a late-stage biopharmaceutical company dedicated to delivering targeted therapies for rare cancers, today announced the…
seekingalpha.com Sierra Oncology: Plenty Of Room To Trade Higher After Latest Myelofibrosis Data Positive results achieved in Phase 3 MOMENTUM study using momelotinib monotherapy for the treatment of myelofibrosis patients who are symptomatic and anemic. Momelotinib has a competitive advantage…
benzinga.com Mid-Morning Market Update: Markets Open Lower; Johnson & Johnson Sales Miss Views Following the market opening Tuesday, the Dow traded down 1.79% to 33,748.82 while the NASDAQ fell 2.56% to 13,499.97. The S&P also fell, dropping, 2.59% to 13,496.29.
benzinga.com 58 Biggest Movers From Yesterday Gainers MediaCo Holding Inc. (NASDAQ: MDIA) shares jumped 311.6% to close at $17.00 on Monday after jumping 20% on Friday.
benzinga.com 64 Biggest Movers From Yesterday Gainers HighPoint Resources Corporation (NYSE: HPR) shares jumped 118.8% to close at $10.83 on Wednesday.
benzinga.com Stocks That Hit 52-Week Highs On Friday During Friday's morning trading, 47 companies set new 52-week highs.- benzinga.com Stocks That Hit 52-Week Highs On Thursday Before 10 a.m. ET on Thursday, 239 stocks hit new 52-week highs.
- benzinga.com Stocks That Hit 52-Week Highs On Wednesday Wednesday morning saw 162 companies set new 52-week highs.
benzinga.com Stocks That Hit 52-Week Highs On Tuesday This morning 279 companies reached new 52-week highs.- benzinga.com 38 Healthcare Stocks Moving In Monday's Pre-Market Session
benzinga.com Stocks That Hit 52-Week Lows On Wednesday - benzinga.com Stocks That Hit 52-Week Lows On Tuesday
- benzinga.com List of Companies Reaching Yearly Lows Tuesday